2020 annual financial data
Spero Therapeutics, Inc. 2020 Operating margin
Spero Therapeutics, Inc. 2020 operating margin with verified reported values.
Direct answer
Operating margin was -847.94%.
Operating income was -79,113,000 USD and net income was -77,519,000 USD.
Operating cash flow was -85,872,000 USD.
Get free Spero Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,330,000 USD
- Operating income
- -79,113,000 USD
- Net income
- -77,519,000 USD
- Operating cash flow
- -85,872,000 USD